Professor Mark Callaway (the RCR’s medical director, professional practice for clinical radiology) talks to Dr Katharine Aitken on the role of stereotactic ablative radiotherapy (SABR) for colorectal cancer. Dr Katharine Aitken is a consultant clinical oncologist based at The Royal Marsden Hospital.

Stereotactic ablative radiotherapy (SABR) for colorectal cancer with Dr Katharine Aitken

Interviews from RCR19, the UK’s leading professional learning and development conference for clinical oncologists and radiologists organised by The Royal College of Radiologists. Over six episodes, guest speakers from RCR19 talk about key issues and latest developments in medical imaging and cancer treatment. Visit www.rcr.ac.uk to find out more.

Share Stereotactic ablative radiotherapy (SABR) for colorectal cancer with Dr Katharine Aitken

Sign up to save your podcasts

Stereotactic ablative radiotherapy (SABR) for colorectal cancer with Dr Katharine Aitken

Stereotactic ablative radiotherapy (SABR) for colorectal cancer with Dr Katharine Aitken